WHY PATIENTS NEED YOU

This 12-month, 80% secondment provides a development opportunity for an experienced clinical operations leader to take enterprise-level accountability for the Pfizer-SCRI/SCDI operational partnership under the Accelero model. The role is positioned within the Global Study Management (GSM) group in Global Site and Study Operations (GSSO), works closely with Strategic Partnerships, and serves as the primary Pfizer operational interface for SCRI and Sarah Cannon Development Innovations (SCDI) across the Accelero portfolio.

WHAT YOU WILL ACHIEVE

The role operates above individual-study execution. It enables portfolio visibility, consistent application of the approved operating model, cross-functional coordination, risk-based oversight, and timely enterprise escalation without duplicating accountabilities held by Study Teams, Vendor Leads, CRO project teams, Quality, or sites.

The successful colleague will gain broad exposure to strategic partnership management, enterprise governance, vendor oversight, operating-model evolution, and senior internal and external stakeholders while contributing to the operational maturity and scalability of a strategically important oncology partnership.

HOW YOU WILL ACHIEVE IT

• Enterprise portfolio oversight: Maintain an integrated view across Accelero studies, including portfolio-level dependencies, recurring risks, trends, and issues requiring cross-study coordination or enterprise action.
• Single operational interface: Act as the primary Pfizer operational point of contact for SCRI/SCDI for Accelero-related operational matters and connect the appropriate Pfizer and partner stakeholders.
• Operating model and Playbook ownership: Own the operational maintenance and evolution of the joint Pfizer-SCRI/SCDI Accelero Playbook, supporting consistent interpretation and application of agreed ways of working, roles, responsibilities, and governance.
• Governance: Prepare for and support effective operational governance forums, ensuring clear agendas, decisions, actions, owners, due dates, and follow-through. Surface matters requiring strategic-partnership or senior-leadership attention.
• Enterprise risk identification and escalation: Identify systemic or cross-study risks early, coordinate root-cause assessment and mitigation, and escalate through the appropriate Pfizer and joint-governance pathways before delivery is affected.
• Quality and exception oversight: Coordinate visibility and management of enterprise quality themes and operating-model exceptions for the Accelero program, ensuring engagement of the appropriate accountable Quality, Study Operations, and vendor-oversight roles.
• Vendor and CRO oversight: Provide enterprise-level operational oversight of SCDI as CRO within the Accelero scope, aligned with Pfizer QMS09 Vendor Oversight Roles, Responsibilities & Expectations (VORRE), without replacing designated Vendor Leads or duplicating study-level oversight.
• Cross-functional alignment: Drive coordination across Strategic Partnerships, Study Operations, Clinical Development, Global Site and Study Operations, Quality, Contracts, Procurement, Finance, and other relevant functions to resolve gaps, clarify ownership, and support consistent execution.
• Performance and continuous improvement: Use portfolio insights, agreed service expectations, and available metrics to identify patterns, recommend improvements, and support a scalable, sustainable operating model.
• Transition and sustainability: Create clear documentation, decision logs, role clarity, and handover materials so that improvements and governance practices remain sustainable beyond the secondment period.

SCOPE AND ROLES BOUNDARIES

In Scope

• Enterprise oversight of the Accelero portfolio.
• Operating-model and Playbook governance.
• Enterprise CRO/vendor oversight and recurring trend visibility.
• Cross-functional coordination and role clarity.
• Enterprise risk identification, mitigation coordination, and escalation.
• Operational governance, decision tracking, and continuous improvement.

Out of Scope

• Direct study execution or ownership of study deliverables.
• Replacement of Study Operations, GSM, Vendor Lead, Quality, or functional accountabilities.
• Day-to-day CRO project management or direct site management.
• Study-level QMS09 execution or individual-study quality assurance.
• Approval authority outside assigned governance and delegated decision rights.
• Duplication of existing study forums, reports, or escalation channels.

QUALIFICATIONS

Must-Have

• Applicant must have a bachelor's degree with at least 8+ years of experience.
• Extensive end-to-end clinical trial operations experience, preferably in oncology and across study start-up, enrollment, maintenance, and closeout.
• Demonstrated understanding of the role of investigative sites, site organizations, CROs, and external partnerships in portfolio delivery.
• Experience managing complex external partners or vendors and working within formal governance and escalation frameworks.
• Strong knowledge of Pfizer clinical-development and GSSO processes, with the ability to connect enterprise expectations to practical operational execution.
• Demonstrated ability to lead cross-functional work in a matrix environment and deliver results through influence rather than direct authority.
• Experience defining, implementing, or improving operating models, processes, governance, or organizational ways of working.
• Strong risk-management, problem-solving, and decision-framing skills, including the judgment to distinguish study-level matters from enterprise issues.
• Executive presence and clear, concise communication with senior internal and external stakeholders; willingness to surface difficult issues constructively.
• Ability to operate effectively in ambiguity, manage competing priorities, and build trust quickly across stakeholder groups.

Nice-to-Have

• Master's degree with at least 7+ years of experience; OR a PhD with 5+ years of experience, OR a MD with 4+ years of experience.
• Working knowledge of vendor oversight, quality management, compliance expectations, procurement, contracts, and budget interfaces relevant to clinical operations is preferred.

KKEY LEADERSHIP CAPABILITIES

• Enterprise and systems thinking.
• Strategic partnership and stakeholder management.
• Influence without authority.
• Governance discipline and accountability.
• Candid, diplomatic communication.
• Risk-based judgment and structured problem solving.
• Operational excellence and continuous improvement.
• Change leadership and ability to navigate ambiguity
  

ORGANIZATIONAL RELATIONSHIPS

• Reports into the Global Study Manager (GSM) group within GSSO.
• Works closely with Strategic Partnerships and partners directly with the Strategic Site Partnerships Lead accountable for the SCRI/SCDI relationship, aligning enterprise operational delivery with the broader partnership strategy and governance.
• Works across Pfizer Study Operations, Clinical Development, Quality, Vendor Oversight, Contracts, Procurement, Finance, and other relevant functions.
• Maintains senior operational relationships with SCRI and SCDI leaders and works with their portfolio, project, quality, contracting, and operational teams.
• Individual contributor role with no direct line-management responsibility.

TERMS AND EXPECTATIONS

• Duration: 12 months.
• Time commitment: 80% of colleague capacity. Any remaining responsibilities must be explicitly agreed with the colleague’s current manager and must not compromise accountability for this role.
• The colleague remains on existing employment terms, compensation, benefits, global job level, and grade, subject to applicable Pfizer policy and local requirements.
• Final start and end dates, transition arrangements, funding, travel and expense coverage, performance objectives, and return plan will be agreed between the host manager, current manager, and selected colleague before the assignment begins.
• Candidates should discuss readiness and the feasibility of release with their current manager before applying.
• Selection will follow the applicable Pfizer secondment posting and interview process.

MEASURES OF SUCESS

• Clear and consistently applied Accelero operating model, with current role definitions and governance documentation.
• Improved enterprise visibility of cross-study risks, dependencies, decisions, and recurring operational themes.
• Timely escalation and coordinated resolution of enterprise issues without displacement of study-level ownership.
• Effective Pfizer-SCRI/SCDI operational governance with documented decisions, accountable owners, and follow-through.
• Actionable continuous-improvement plan supported by lessons learned and portfolio insights.
• Complete sustainability and handover package at the conclusion of the secondment.

 
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

OTHER JOB DETAILS

• Last Date to Apply for Job: November 3, 2026
• Additional Location Information: North America - Remote, USA - Remote,
• Eligible for Relocation Package – NO
• Secondment 12 months
• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.
• There will be no change to your current work location.
• Note: This secondment offers a valuable opportunity for professional growth. It will need to be funded by the secondee’s home market.

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.